Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
22.68
+0.25 (1.11%)
At close: Mar 4, 2026, 4:00 PM EST
22.68
0.00 (0.00%)
After-hours: Mar 4, 2026, 4:27 PM EST
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $2.84 billion as of March 4, 2026. Its market cap has increased by 144.62% in one year.
Market Cap
2.84B
Enterprise Value
2.03B
1-Year Change
144.62%
Ranking
Category
Stock Price
$22.68
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $2.84B, an increase of 303.52%. That is a compound annual growth rate of 19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 3.00B | 1.78% |
| Dec 31, 2025 | 2.95B | 116.38% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Denali Therapeutics | 3.35B |
| Spyre Therapeutics | 3.34B |
| Tarsus Pharmaceuticals | 3.29B |
| Edgewise Therapeutics | 3.18B |
| Arcutis Biotherapeutics | 3.10B |
| Viridian Therapeutics | 3.09B |
| IDEAYA Biosciences | 2.94B |
| Vera Therapeutics | 2.91B |